Joint Filer Information
| Names: | Deerfield Management Company, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Private Design Fund III, L.P. |
| | |
| Address: | 345 Park Avenue South, 12th Floor |
| | New York, NY 10010 |
| | |
| Designated Filer: | James E. Flynn |
| | |
| Issuer and Ticker Symbol: | ARS Pharmaceuticals, Inc. [SPRY] |
| | |
| Date of Event Requiring Statement: | November 11, 2024 |
The undersigned, Deerfield Management Company, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Private Design Fund III, L.P., are jointly filing the attached Statement of Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of ARS Pharmaceuticals, Inc.
Signatures:
DEERFIELD MANAGEMENT COMPANY, L.P. By: Flynn Management LLC, General Partner By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact | DEERFIELD MGMT IV, L.P. By: J.E. Flynn Capital IV, LLC, General Partner By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |
DEERFIELD MGMT III, L.P. By: J.E. Flynn Capital, LLC, General Partner By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact | DEERFIELD PRIVATE DESIGN FUND IV, L.P. By: Deerfield Mgmt IV, L.P., General Partner By: J.E. Flynn Capital IV, LLC, General Partner By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |
DEERFIELD PRIVATE DESIGN FUND III, L.P. By: Deerfield Mgmt III, L.P., General Partner By: J.E. Flynn Capital III, LLC, General Partner By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact | |
